rs7533978

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_024408.4(NOTCH2):​c.939C>T​(p.Gly313Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00478 in 1,614,062 control chromosomes in the GnomAD database, including 323 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 152 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 171 hom. )

Consequence

NOTCH2
NM_024408.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.193

Publications

2 publications found
Variant links:
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
  • acroosteolysis dominant type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome due to a NOTCH2 point mutation
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 1-119969680-G-A is Benign according to our data. Variant chr1-119969680-G-A is described in ClinVar as Benign. ClinVar VariationId is 532030.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.193 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.083 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH2NM_024408.4 linkc.939C>T p.Gly313Gly synonymous_variant Exon 6 of 34 ENST00000256646.7 NP_077719.2 Q04721Q6IQ50Q9UFD5
NOTCH2NM_001200001.2 linkc.939C>T p.Gly313Gly synonymous_variant Exon 6 of 22 NP_001186930.1 Q04721Q6IQ50

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH2ENST00000256646.7 linkc.939C>T p.Gly313Gly synonymous_variant Exon 6 of 34 1 NM_024408.4 ENSP00000256646.2 Q04721
NOTCH2ENST00000479412.2 linkn.1077C>T non_coding_transcript_exon_variant Exon 5 of 14 1
NOTCH2ENST00000640021.1 linkn.*63C>T non_coding_transcript_exon_variant Exon 3 of 12 5 ENSP00000492223.1 A0A1W2PQQ5
NOTCH2ENST00000640021.1 linkn.*63C>T 3_prime_UTR_variant Exon 3 of 12 5 ENSP00000492223.1 A0A1W2PQQ5

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3745
AN:
152126
Hom.:
151
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0855
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00923
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.0187
GnomAD2 exomes
AF:
0.00635
AC:
1593
AN:
250998
AF XY:
0.00435
show subpopulations
Gnomad AFR exome
AF:
0.0867
Gnomad AMR exome
AF:
0.00361
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000353
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00271
AC:
3965
AN:
1461818
Hom.:
171
Cov.:
33
AF XY:
0.00230
AC XY:
1674
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.0927
AC:
3104
AN:
33474
American (AMR)
AF:
0.00416
AC:
186
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5766
European-Non Finnish (NFE)
AF:
0.000255
AC:
284
AN:
1111966
Other (OTH)
AF:
0.00594
AC:
359
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
228
457
685
914
1142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0246
AC:
3750
AN:
152244
Hom.:
152
Cov.:
32
AF XY:
0.0240
AC XY:
1783
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0854
AC:
3545
AN:
41526
American (AMR)
AF:
0.00921
AC:
141
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68020
Other (OTH)
AF:
0.0185
AC:
39
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
170
340
511
681
851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0143
Hom.:
38
Bravo
AF:
0.0282
Asia WGS
AF:
0.00404
AC:
15
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000593

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hajdu-Cheney syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
11
DANN
Benign
0.70
PhyloP100
0.19
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=68/32
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7533978; hg19: chr1-120512303; API